A new analysis provides substantial evidence that paramagnetic rim lesions drive disability in MS and are targetable with a ...

Roche’s Genentech unit has received approval from the US Food and Drug Administration (FDA) for TNKase (tenecteplase) in ...

Genentech, a Roche Group company(OTCQX:RHHBY) said on Wednesday that the U.S. FDA accepted the company’s supplemental ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) for Gazyva®/Gazyvaro® ...

Subcutaneous administration of trastuzumab and pertuzumab significantly shortened the time patients with stage I ...

An in-depth analysis of 50+ companies and 65+ pipeline drugs shaping the Molecular Glue market. The report covers therapeutics assessment by product type, development stage, route of administration, ...

US FDA accepts Roche’s Gazyva/Gazyvaro sBLA for the treatment of lupus nephritis: Basel Thursday, March 6, 2025, 09:00 Hrs [IST] Roche announced that the US Food and Drug Admini ...

The U.S. Food and Drug Administration (FDA) has accepted Genentech’s Supplemental Biologics License Application (sBLA) for ...

Percentages of children with peanut allergy who responded to treatment with the VP250 VIASKIN Peanut patch from DBV Technologies increased from 12 months through 60 months, according to an abstract ...

Omalizumab superior to oral immunotherapy for multifood allergy, and most patients consume allergy-triggering foods after gaining tolerance.

A former Stanford employee is scheduled to be sentenced this July after having allegedly altered breast cancer research data more than 10 years ago.

VerifiedEmail solves a challenge every online business faces: ensuring every email reaches its intended recipient. Born from our struggles with email deliverability, VerifiedEmail swiftly and ...